Dr. Melissa Mary Hardesty, MD
- Medicare services, 2024
- 423
- Medicare patients, 2024
- 214
- Part D claims, 2024
- 792
- Publications
- 10
- Clinical trials
- 4
- Practice address
- 3200 Providence Drive, Anchorage, AK 99508
- Practice phone
- Call (907) 562-2211
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Hardesty's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Melissa Mary Hardesty is a gynecologic oncologist in Anchorage, Alaska
Dr. Hardesty practices at Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services.
Dr. Hardesty's NPI, 1821092362, was assigned on June 13, 2005. Dr. Hardesty graduated from Albany Medical College of Union University in 2001. Dr. Hardesty holds Alaska license 7749.
- NPI
- 1821092362NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2466499082
- NPI enumeration date
- June 13, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (907) 562-2211
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 51
- Medical school graduation
- 2001
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Melissa Mary Hardesty practices at Providence Alaska Medical Center in Anchorage, Alaska
Dr. Hardesty's primary practice is Providence Alaska Medical Center, at 3200 Providence Drive, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 562-2211.
- Providence Alaska Medical Center3200 Providence Drive, Anchorage, AK 99508 · Anchorage BoroughPhone(907) 562-2211
Source: Dmand AI Affiliation Data
Dr. Melissa Mary Hardesty is affiliated with 8 sites of care and 3 medical groups
Dr. Hardesty's primary practice is Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services. Dr. Hardesty is also affiliated with Alaska Native Medical Center. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Hardesty to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Melissa Mary Hardesty's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hardesty practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Providence Alaska Medical Center | Available with a free account |
| +7 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Providence Health & Services and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Melissa Mary Hardesty is one of 3 gynecologic oncologists in Alaska
Gynecologic oncology is Dr. Hardesty's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Hardesty is licensed in Alaska.
Specialties and state licenses
- Gynecologic oncology, AlaskaPrimary
Gynecologic oncologists near Dr. Hardesty
Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Melissa Mary Hardesty billed Medicare for 423 services in 2024
CMS data shows 423 Medicare services from Dr. Hardesty across 6 procedure codes in 2024, for 214 Medicare patients. Medicare paid $79,559 for them.
Dr. Hardesty's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3892024: 3724%
- Surgery
- 2023: 392024: 5131%
Where Dr. Hardesty's Medicare services took place, 2024
- In an office35584%
- In a facility6816%
Dr. Hardesty's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Hardesty?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Hardesty and other gynecologic oncologists in Alaska.
Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data
Dr. Melissa Mary Hardesty treated 214 Medicare patients in 2024, average age 71
CMS counts 214 Medicare patients who saw Dr. Hardesty in 2024. The largest group is 65 to 74, with 129 patients. 66% of them have high blood pressure, and 56% have cancer. 21% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Hardesty's median patient age at 69, with 100% women.
Dr. Hardesty's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Hardesty's Medicare patients, 2024
- High blood pressure66%
- Cancer56%
- High cholesterol55%
- Diabetes31%
- Arthritis30%
- Chronic kidney disease24%
- Anxiety23%
- Ischemic heart disease22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Hardesty's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women100%
- Men0%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Melissa Mary Hardesty wrote 792 Medicare Part D claims in 2024
In 2024, Dr. Hardesty wrote 792 Medicare Part D claims for 125 patients. 79% of them were for generic drugs. CMS names the drug for 589 of them, across 21 drugs with 11 or more claims each, at $894,752 in total drug cost. In 2023, CMS named 586 claims across 21 drugs.
Dr. Hardesty's Part D claims by kind of drug, 2024
- Generic629 claims79%
- Brand-name163 claims21%
Dr. Hardesty's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Hardesty's Part D claims, 2024
- Opioids8%64 of 792 claims
- Antibiotics2%13 of 792 claims
- Antipsychotics, patients 65 and over4%30 of 792 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5862024: 5891%
Drugs named by CMS: 21 in 2024, 21 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Melissa Mary Hardesty scored 91 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Hardesty for performance year 2024, reported as part of a group. Dr. Hardesty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hardesty as offering telehealth. CMS counts 28 procedures of removal of the uterus by Dr. Hardesty, more than 96% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Hardesty's MIPS scores, performance year 2024
- 91of 100Final score
- 70.1of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 83of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Where Dr. Hardesty ranks in Medicare procedure volume
- Removal of the uterus
- 96th percentile28 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)
Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Melissa Mary Hardesty has 10 publications on record
Dmand AI links 10 papers to Dr. Hardesty, published from 2015 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Carcinoma, Ovarian Epithelial and Ovarian Neoplasms. Dr. Hardesty has published most often in Gynecol Oncol. Dr. Hardesty's most frequent co-authors are Barbara Ann Goff, Renata Rose Urban, MD and Edwin A. Alvarez, MD.
Dr. Hardesty's papers by year, 2015 to 2025
Topics Dr. Hardesty writes about most
- Carcinoma, Ovarian Epithelial
- Ovarian Neoplasms
Dr. Hardesty's most frequent co-authors
- Barbara Ann Goff3 shared papers
- Renata Rose Urban, MD3 shared papers
- Edwin A. Alvarez, MD1 shared paper
Recent publications by Dr. Hardesty
See who Dr. Hardesty researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Hardesty works with, so you can find a warm path to the right gynecologic oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Melissa Mary Hardesty has worked on 4 clinical trials
Dmand AI links Dr. Hardesty to 4 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Fallopian Tube Diseases, Fallopian Tube Neoplasms and Carcinoma, Ovarian Epithelial. AbbVie sponsors the most, 2.
Clinical trials with Dr. Hardesty by phase
- 1Phase 1: 1 trial
- 2Phase 2: 2 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Hardesty's trials
- Fallopian Tube Diseases
- Fallopian Tube Neoplasms
- Carcinoma, Ovarian Epithelial
- Endometrial Neoplasms
- Uterine Neoplasms
Investigators on the most trials with Dr. Hardesty
- Sharyn N. Lewin, MD3 shared trials
- Charles Kellogg Anderson, MD2 shared trials
- Margarett Conklin Ellison, MD2 shared trials
Recent clinical trials with Dr. Hardesty
A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Melissa Mary Hardesty received $89,778 in industry payments from 2016 to 2025
CMS Open Payments shows 168 general payments to Dr. Hardesty from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. AstraZeneca Pharmaceuticals LP paid the most, $35,012.
General payments to Dr. Hardesty by program year, 2016 to 2025
General payments to Dr. Hardesty by kind, 2016 to 2025
- Consulting fees$72,03280%
- Food and beverage$6,4407%
- Education$4,3685%
- Speaker and faculty fees$4,2705%
- Travel and lodging$2,6683%
Companies that paid Dr. Hardesty the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Melissa Mary Hardesty graduated from Albany Medical College of Union University
Dr. Hardesty graduated from Albany Medical College of Union University in 2001.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Melissa Mary Hardesty's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Melissa Mary Hardesty
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Melissa Mary Hardesty's NPI number?
Dr. Melissa Mary Hardesty's NPI number is 1821092362. It was assigned on June 13, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Melissa Mary Hardesty?
Dr. Melissa Mary Hardesty is a gynecologic oncologist in Anchorage, Alaska. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).
Where does Dr. Melissa Mary Hardesty practice?
Dr. Hardesty practices at 3200 Providence Drive, Anchorage, AK 99508. Dr. Hardesty's primary practice is Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services. Dmand AI also links Dr. Hardesty to 3 hospitals, 3 group practices and clinics and 2 medical groups.
What is Dr. Melissa Mary Hardesty's office phone number?
The practice phone on file for Dr. Hardesty is (907) 562-2211.
What is Dr. Melissa Mary Hardesty's medical license number?
Dr. Hardesty holds Alaska license 7749.
Which hospitals is Dr. Melissa Mary Hardesty affiliated with?
Dr. Hardesty practices at Providence Alaska Medical Center in Anchorage, Alaska. Dr. Hardesty is also affiliated with Alaska Native Medical Center. Dmand AI links Dr. Hardesty to 3 more hospitals.
What medical group is Dr. Melissa Mary Hardesty part of?
Dr. Hardesty is linked to Alaska Native Medical Center. Dmand AI links Dr. Hardesty to 2 more medical groups.
Does Dr. Melissa Mary Hardesty accept Medicare?
Yes. CMS data shows Dr. Hardesty billed Medicare for 423 services in 2024, and Dr. Hardesty accepts Medicare assignment.
Does Dr. Melissa Mary Hardesty offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Hardesty as offering telehealth services.
What is Dr. Melissa Mary Hardesty's MIPS score?
Dr. Hardesty's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Melissa Mary Hardesty see?
CMS counts 214 Medicare patients who saw Dr. Hardesty in 2024, with an average age of 71.
What services does Dr. Melissa Mary Hardesty bill to Medicare?
In 2024, Dr. Hardesty's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and office visit, new patient (99205).
Where did Dr. Melissa Mary Hardesty go to medical school?
Dr. Hardesty graduated from Albany Medical College of Union University in 2001.
What drugs does Dr. Melissa Mary Hardesty prescribe most?
In 2024 Medicare Part D data, Dr. Hardesty's most prescribed drugs by claims were Omeprazole, Dexamethasone and Letrozole.
Has Dr. Melissa Mary Hardesty received payments from drug or device companies?
CMS Open Payments shows $89,778 in general payments to Dr. Hardesty from 22 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Melissa Mary Hardesty been practicing?
Dr. Hardesty graduated from medical school in 2001, 25 years ago.
Does Dr. Melissa Mary Hardesty do research?
Dmand AI links 10 publications to Dr. Hardesty, published from 2015 to 2025. Dr. Hardesty has worked on 4 clinical trials.
Who does Dr. Melissa Mary Hardesty publish with?
Dr. Hardesty's most frequent co-authors are Barbara Ann Goff (3 shared papers), Renata Rose Urban, MD (3 shared papers) and Edwin A. Alvarez, MD (1 shared paper).
Selling to gynecologic oncology practices?
See gynecologic oncologists in Alaska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card